what works better tirzepatide or semaglutide vs Tirzepatide: Which for Weight Loss? Tirzepatide vs. Semaglutide: What You

Like other incretin-based medications, the most common side effects were gastrointestinal: Common Side Effects Nausea: Reported in approximately 25-45% of participants depending on dose (most common during titration) Diarrhea: Approximately 20-35% of participants Vomiting: Approximately 10-20% of participants Constipation: Approximately 10-15% of participants Decreased appetite: Common and expected given the mechanism of action Less Common but Notable Effects Increased heart rate: Small elevations in resting heart rate were observed, consistent with other GLP-1 class medications Injection site reactions: Mild redness or itching at injection sites Fatigue: Reported by some participants, particularly during dose escalation Most adverse events were mild to moderate and occurred primarily during the dose escalation phase

SURMOUNT-OSA showed AHI reduction of about 27 events per hour in the treatment arm

Long-term use of some type 2 diabetes medications can reduce B12 absorption

Promotes sustainable weight loss and overall metabolic wellness

Cancer cells preferentially import extracellular cystine over cysteine via the cystine-glutamate antiporter System XC (SLC7A11/xCT)